MYOS RENS Technology, Inc.

MYOS RENS Technology, Inc. (MYOS) relating to its merger with MedAvail, Inc. Under the terms of the agreement, MYOS shareholders receive a dividend of a MYOS subsidiary, and MYOS shareholders will own only 3.5% of the new combined company. The remaining 96.5% of the new entity will be owned by MedAvail’s security holders and new investors.

Intro

The investigation is focused on whether the process and price are fair. To receive more information regarding the investigation of MYOS RENS Technology, Inc. please fill out the form below.

upper group

First/Last Name

Email *

Address

City/State/Zip

Daytime Telephone

Evening Telephone

Shares Owned

Purchase Date

join

Join Action

lower group

confirm

To start a Class Action lawsuit, please sign the MYOS RENS Technology, Inc. Retainer Agreement

This confirms that you have retained Monteverde & Associates PC to pursue claims on your behalf and/or file a class action against the MYOS RENS Technology, Inc. and/or its board of directors or officers with you as a named plaintiff and on a fully contingent basis with respect to our fees. Further, you purchased the shares prior to the announcement of the corporate action sought by the board of directors for MYOS RENS Technology, Inc. and you did not buy said shares to commence any legal action. Furthermore, you must preserve all documents and communications related to MYOS RENS Technology, Inc..

We agree to advance all expenses in the litigation, which means that you are not liable or responsible to pay any of the expenses of the action, whether attorneys’ fees or costs. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees or costs. Should we obtain a favorable result, you authorize us to explore a release of all claims, and ask the court to award us compensation up to one-third of any monetary class fund plus expenses, or to negotiate/obtain a mootness fee with the company or defendants, but, we will never ask you to pay any of the fees or costs.

As the client you are entitled to direct the litigation in any way you deem proper, and may at any time order us to dismiss the case or opt-out. Should you choose to do so, we will never ask you to reimburse us directly for any legal fees or expenses. During the course of this litigation, you authorize us to employ, share work and/or fees with other attorneys or law firms to prosecute your case. Further, the file compiled in the case constitutes the work product and property of this firm over which the firm has complete control with respect to its use and/or disclosure.

We look forward to representing you in this case.

Juan E. Monteverde, Esq.

AGREED: Sign Name

Signature

1633

Signed pursuant to California Civil Code Section 1633. 1, et seq. – Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of Signing

Date of Signing: 09/02/2026